Warsaw Breakage Syndrome – Definition

Warsaw Breakage Syndrome (OMIN #613398) is a hereditary syndromic disorder associated with increased chromosomal fragility and, thus, an increased risk of cancer. It is caused by a defect in the DDX11 gene, which is considered a tumor suppressor, among other things. The typical symptom triad is microcephaly, growth retardation, and deafness, which is often accompanied by cochlear malformations.

Synonym:

WABS

Gene:

DDX11 (ChlR1)

Gen­e product:

ATP-dependent DNA helicase DDX11

Function:

Sister chromatid cohesion and DNA replication, tumor suppressor

Pattern of inheritance:

Autosomal recessive

Prevalence:

Currently 23 cases described worldwide

Genotype-phenotype correlation:

Penetrance:

Unknown

Overview of the Chapters on This Page:

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

Warsaw Breakage Syndrome – Diagnosis

Characteristic clinic in connection with the molecular genetic detection of a biallelic/homozygous pathogenic variant in the DDX11 gene.

  • Analysis of the DDX11 gene
  • DDX11 sequence analysis as a standard test
  • In the absence of homozygous pathogenic variant detection, a targeted DDX11 deletion or duplication analysis is recommended.
  • Multi-gene panel

In the absence of clinical or phenotypic evidence for WABS:

  • Exome or genome sequencing

Differential Diagnoses

Clinical Presentation

  • Congenital microcephaly
  • Pre- and postnatal growth retardation
  • Cochlear hypoplasia with congenital deafness
  • Intellectual disability and developmental delay
  • Cardiovascular malformations
  • Skeletal malformations (radial ray and thumb)

Individual abnormalities described:

  • Pigmentary disorders of the skin
  • Urogenital malformation
  • Premature menarche

Cancer Predisposition

Due to the increased chromosomal fragility, an increased risk of cancer is assumed. However, due to the low prevalence, there are currently no precise estimates of the frequency and entity of cancers in the context of WABS.

Special Features of Treatment

  • Optimization of the nutritional situation to promote sufficient growth and regular pediatrician checks of weight, height, head circumference, and BMI
  • Cochlear implant with existing cochlear nerve

Diagnose Warsaw Breakage Syndrome. Wie geht es weiter?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Diagnosis of Warsaw Breakage Syndrome- What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Recommendations for Early Detection in Your Patients

Due to the limited data available, no uniform, evidence-based screening recommendations exist.

  • Regular clinical checks and, if necessary, further diagnostics in the event of abnormal findings

Warsaw Breakage Syndrome – Further Information

Open Clinical Trials/ Registries

Additional Resources

Unfortunately, we are currently not aware of any support groups for patients with Warsaw Breakage syndrome. New information will be added as soon as it becomes available.